The recent challenges in global distribution have highlighted the necessity of securing vital medications like Ivermectin. Dependence on overseas manufacturers exposes nations to considerable vulnerabilities, including transportation delays, price fluctuations, and even geopolitical risks. Transitioning towards domestic production of Ivermectin off